Shopping Cart 0
Cart Subtotal
USD 0

PharmAust Ltd (PAA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

PharmAust Ltd (PAA) is a clinical-stage company that focuses on the development of targeted cancer therapeutics for the treatment of human and veterinary cancers. The company's lead product candidate Monepantel is a small molecule that has been developed to treat parasite infections in food chain animals. MPL is an oral aminoacetonitrile compound that modulates the mTOR pathway. The company's products are used in the treatment of multiple human indications including breast cancer, renal cell carcinoma, mantle cell lymphoma and pancreatic neuroendocrine tumours, Alzheimer's, Parkinson's and various ageing disorders. It has operations in Claremont and Bentley. PharmAust is headquartered in Bentley, Western Australia, Australia.

PharmAust Ltd (PAA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

PharmAust Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

PharmAust Ltd, Medical Devices Deals, 2012 to YTD 2018 10

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

PharmAust Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Pitney Pharma Enters into Agreement with NewSouth Innovations 12

Licensing Agreements 13

PharmAust Enters into Agreement with Nihon Nohyaku 13

PharmAust Enters into Licensing Agreement with NewSouth Innovations 14

Equity Offering 15

PharmAust Raises USD1.4 Million in Private Placement of Shares 15

PharmAust Raises Additional Funds in Rights Offering of Shares 16

PharmAust Raises Additional USD1.2 Million in Rights Offering of Shares 17

PharmAust Raises Funds through Rights Offering of Shares 18

PharmAust Raises USD2.4 Million in Private Placement of Shares 19

PharmAust Completes Private Placement Of Shares For USD 0.8 Million 20

PharmAust Completes Private Placement Of Shares For USD 0.2 Million 21

PharmAust Completes Private Placement Of Shares For USD 4.5 Million 22

PharmAust Completes Private Placement Of Shares For USD 2.3 Million 23

PharmAust Completes Private Placement Of Shares For USD 0.52 Million 24

Acquisition 25

PharmAust Completes Acquisition Of Pitney Pharma, Cancer Drug Platforms Developer 25

PharmAust Ltd-Key Competitors 26

PharmAust Ltd-Key Employees 27

PharmAust Ltd-Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Recent Developments 29

Corporate Communications 29

May 21, 2018: PharmAust: Chief Executive Officer resigns 29

Dec 18, 2017: International Vet Cancer Specialist Joins PharmAust Veterinary Advisory Board 30

Mar 08, 2017: Dr Richard Mollard appointed as Chief Scientific Officer of PharmAust 31

Mar 01, 2017: Dr Richard Hopkins Appointed as CEO of PharmAust 32

Legal and Regulatory 33

Jul 02, 2018: Epichem gains prestigious international ISO accreditation 33

Other Significant Developments 34

Jan 31, 2018: PharmAust Appendix 4C and Shareholders Update (Q2, 2018 FY) 34

Jan 18, 2018: Epichem Awarded One Year Contract Extension from DNDi 36

Nov 29, 2017: PharmAust Launches New Corporate Website 37

Oct 26, 2017: PharmAust: Appendix 4C-Quarterly Report and Company Update for the period ended 30 September 2017 38

Apr 13, 2017: PharmAust: Quarterly Report & Company Update for the period ended 31 March 2017 40

Jan 31, 2017: PharmAust: Quarterly Report & Company Update for the period ended 31 December 2016 42

Appendix 43

Methodology 43

About GlobalData 43

Contact Us 43

Disclaimer 43


List Of Figure

List of Figures

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

PharmAust Ltd, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

PharmAust Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

PharmAust Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

PharmAust Ltd, Deals By Therapy Area, 2012 to YTD 2018 9

PharmAust Ltd, Medical Devices Deals, 2012 to YTD 2018 10

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Pitney Pharma Enters into Agreement with NewSouth Innovations 12

PharmAust Enters into Agreement with Nihon Nohyaku 13

PharmAust Enters into Licensing Agreement with NewSouth Innovations 14

PharmAust Raises USD1.4 Million in Private Placement of Shares 15

PharmAust Raises Additional Funds in Rights Offering of Shares 16

PharmAust Raises Additional USD1.2 Million in Rights Offering of Shares 17

PharmAust Raises Funds through Rights Offering of Shares 18

PharmAust Raises USD2.4 Million in Private Placement of Shares 19

PharmAust Completes Private Placement Of Shares For USD 0.8 Million 20

PharmAust Completes Private Placement Of Shares For USD 0.2 Million 21

PharmAust Completes Private Placement Of Shares For USD 4.5 Million 22

PharmAust Completes Private Placement Of Shares For USD 2.3 Million 23

PharmAust Completes Private Placement Of Shares For USD 0.52 Million 24

PharmAust Completes Acquisition Of Pitney Pharma, Cancer Drug Platforms Developer 25

PharmAust Ltd, Key Competitors 26

PharmAust Ltd, Key Employees 27

PharmAust Ltd, Other Locations 28

PharmAust Ltd, Subsidiaries 28

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

PharmAust Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

PharmAust Ltd (PAA) is a clinical-stage company that focuses on the development of targeted cancer therapeutics for the treatment of human and veterinary cancers. The company's lead product candidate Monepantel is a small molecule that has been developed to treat parasite infections in food chain animals. MPL is an oral aminoacetonitrile compound that modulates the mTOR pathway. The company's products are used in the treatment of multiple human indications including breast cancer, renal cell carcinoma, mantle cell lymphoma and pancreatic neuroendocrine tumours, Alzheimer's, Parkinson's and various ageing disorders. It has operations in Claremont and Bentley. PharmAust is headquartered in Bentley, Western Australia, Australia.

PharmAust Ltd (PAA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

PharmAust Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

PharmAust Ltd, Medical Devices Deals, 2012 to YTD 2018 10

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

PharmAust Ltd, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

Pitney Pharma Enters into Agreement with NewSouth Innovations 12

Licensing Agreements 13

PharmAust Enters into Agreement with Nihon Nohyaku 13

PharmAust Enters into Licensing Agreement with NewSouth Innovations 14

Equity Offering 15

PharmAust Raises USD1.4 Million in Private Placement of Shares 15

PharmAust Raises Additional Funds in Rights Offering of Shares 16

PharmAust Raises Additional USD1.2 Million in Rights Offering of Shares 17

PharmAust Raises Funds through Rights Offering of Shares 18

PharmAust Raises USD2.4 Million in Private Placement of Shares 19

PharmAust Completes Private Placement Of Shares For USD 0.8 Million 20

PharmAust Completes Private Placement Of Shares For USD 0.2 Million 21

PharmAust Completes Private Placement Of Shares For USD 4.5 Million 22

PharmAust Completes Private Placement Of Shares For USD 2.3 Million 23

PharmAust Completes Private Placement Of Shares For USD 0.52 Million 24

Acquisition 25

PharmAust Completes Acquisition Of Pitney Pharma, Cancer Drug Platforms Developer 25

PharmAust Ltd-Key Competitors 26

PharmAust Ltd-Key Employees 27

PharmAust Ltd-Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Recent Developments 29

Corporate Communications 29

May 21, 2018: PharmAust: Chief Executive Officer resigns 29

Dec 18, 2017: International Vet Cancer Specialist Joins PharmAust Veterinary Advisory Board 30

Mar 08, 2017: Dr Richard Mollard appointed as Chief Scientific Officer of PharmAust 31

Mar 01, 2017: Dr Richard Hopkins Appointed as CEO of PharmAust 32

Legal and Regulatory 33

Jul 02, 2018: Epichem gains prestigious international ISO accreditation 33

Other Significant Developments 34

Jan 31, 2018: PharmAust Appendix 4C and Shareholders Update (Q2, 2018 FY) 34

Jan 18, 2018: Epichem Awarded One Year Contract Extension from DNDi 36

Nov 29, 2017: PharmAust Launches New Corporate Website 37

Oct 26, 2017: PharmAust: Appendix 4C-Quarterly Report and Company Update for the period ended 30 September 2017 38

Apr 13, 2017: PharmAust: Quarterly Report & Company Update for the period ended 31 March 2017 40

Jan 31, 2017: PharmAust: Quarterly Report & Company Update for the period ended 31 December 2016 42

Appendix 43

Methodology 43

About GlobalData 43

Contact Us 43

Disclaimer 43


List Of Figure

List of Figures

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

PharmAust Ltd, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

PharmAust Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

PharmAust Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

PharmAust Ltd, Deals By Therapy Area, 2012 to YTD 2018 9

PharmAust Ltd, Medical Devices Deals, 2012 to YTD 2018 10

PharmAust Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Pitney Pharma Enters into Agreement with NewSouth Innovations 12

PharmAust Enters into Agreement with Nihon Nohyaku 13

PharmAust Enters into Licensing Agreement with NewSouth Innovations 14

PharmAust Raises USD1.4 Million in Private Placement of Shares 15

PharmAust Raises Additional Funds in Rights Offering of Shares 16

PharmAust Raises Additional USD1.2 Million in Rights Offering of Shares 17

PharmAust Raises Funds through Rights Offering of Shares 18

PharmAust Raises USD2.4 Million in Private Placement of Shares 19

PharmAust Completes Private Placement Of Shares For USD 0.8 Million 20

PharmAust Completes Private Placement Of Shares For USD 0.2 Million 21

PharmAust Completes Private Placement Of Shares For USD 4.5 Million 22

PharmAust Completes Private Placement Of Shares For USD 2.3 Million 23

PharmAust Completes Private Placement Of Shares For USD 0.52 Million 24

PharmAust Completes Acquisition Of Pitney Pharma, Cancer Drug Platforms Developer 25

PharmAust Ltd, Key Competitors 26

PharmAust Ltd, Key Employees 27

PharmAust Ltd, Other Locations 28

PharmAust Ltd, Subsidiaries 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

PharmAust Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.